Predictive Biosciences, a Lexington, MA-based developer of diagnostics, said today it has acquired Cleveland, OH-based OncoDiagnostic Laboratory. By acquiring the company, founded in 1985, Predictive has obtained a certified pathology lab that serves urologists, gastroenterologists, dermatologists and other specialty physicians around the country. The facility will provide a commercial base of operation for Predictive, which is seeking to commercialize a non-invasive, urine-based diagnostic test for bladder cancer during 2010.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
